Order Article Reprints

Kovács PT, Mayer T, Csizmarik A, Váradi M, Oláh C, Széles Á, Tschirdewahn S, Krafft U, Hadaschik B, Nyirády P, et al. Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. Biomedicines. 2022; 10(3):698. https://doi.org/10.3390/biomedicines10030698

Kovács, Petra Terézia, Tamás Mayer, Anita Csizmarik, Melinda Váradi, Csilla Oláh, Ádám Széles, Stephan Tschirdewahn, Ulrich Krafft, Boris Hadaschik, Péter Nyirády, and et al. 2022. "Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma" Biomedicines 10, no. 3: 698. https://doi.org/10.3390/biomedicines10030698

Kovács, P. T., Mayer, T., Csizmarik, A., Váradi, M., Oláh, C., Széles, Á., Tschirdewahn, S., Krafft, U., Hadaschik, B., Nyirády, P., Riesz, P., & Szarvas, T. (2022). Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. Biomedicines, 10(3), 698. https://doi.org/10.3390/biomedicines10030698